Safety and Efficacy of Ospemifene in Women with A History of Breast Cancer-Journal of Gynecology and Women’s Health-Juniper Publishers
juniperpublishers (noreply@blogger.com)
JUNIPER PUBLISHERS-Journal of Gynecology and Women’s Health Safety and Efficacy of Ospemifene in Women with A History of Breast Cancer Authored by Nico Bruyniks* This post-hoc analysis compares the
efficacy and safety data from women with or without a history of breast cancer
who had been enrolled in the ospemifene clinical trial program. Efficacy was
assessed by the co-primary endpoints of most bothersome symptom (MBS; pooled
data from two studies) and mean baseline to Week 12 change in vaginal
